IL160131A0 - Topical composition for follicular delivery of an ornithine decarboxylase inhibitor - Google Patents

Topical composition for follicular delivery of an ornithine decarboxylase inhibitor

Info

Publication number
IL160131A0
IL160131A0 IL16013102A IL16013102A IL160131A0 IL 160131 A0 IL160131 A0 IL 160131A0 IL 16013102 A IL16013102 A IL 16013102A IL 16013102 A IL16013102 A IL 16013102A IL 160131 A0 IL160131 A0 IL 160131A0
Authority
IL
Israel
Prior art keywords
topical composition
ornithine decarboxylase
decarboxylase inhibitor
follicular delivery
follicular
Prior art date
Application number
IL16013102A
Other languages
English (en)
Original Assignee
Women First Healthcare Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Women First Healthcare Inc filed Critical Women First Healthcare Inc
Publication of IL160131A0 publication Critical patent/IL160131A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL16013102A 2001-08-15 2002-08-13 Topical composition for follicular delivery of an ornithine decarboxylase inhibitor IL160131A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31265701P 2001-08-15 2001-08-15
PCT/US2002/025754 WO2003015729A1 (en) 2001-08-15 2002-08-13 Topical composition for follicular delivery of an ornithine decarboxylase inhibitor

Publications (1)

Publication Number Publication Date
IL160131A0 true IL160131A0 (en) 2004-06-20

Family

ID=23212429

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16013102A IL160131A0 (en) 2001-08-15 2002-08-13 Topical composition for follicular delivery of an ornithine decarboxylase inhibitor
IL160131A IL160131A (en) 2001-08-15 2004-01-29 Topical composition for follicular delivery of an ornithine decarboxylase inhibitor

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL160131A IL160131A (en) 2001-08-15 2004-01-29 Topical composition for follicular delivery of an ornithine decarboxylase inhibitor

Country Status (14)

Country Link
US (1) US7374770B2 (xx)
EP (1) EP1416907A4 (xx)
JP (1) JP3981074B2 (xx)
KR (1) KR100722001B1 (xx)
CN (1) CN1320878C (xx)
AR (1) AR035133A1 (xx)
AU (1) AU2002324699B2 (xx)
CA (1) CA2455231C (xx)
HK (1) HK1073060A1 (xx)
IL (2) IL160131A0 (xx)
MX (1) MXPA04001137A (xx)
NZ (1) NZ531006A (xx)
RU (1) RU2004107843A (xx)
WO (1) WO2003015729A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743822B2 (en) 2001-08-10 2004-06-01 The Gillette Company Reduction of hair growth
US7261878B2 (en) 2001-08-10 2007-08-28 The Gillette Company Reduction of hair growth
US20030036561A1 (en) * 2001-08-10 2003-02-20 Peter Styczynski Reduction of hair growth
US20030199584A1 (en) * 2002-04-11 2003-10-23 Ahluwalia Gurpreet S. Reduction of hair growth
US7015349B2 (en) * 2003-03-26 2006-03-21 The Gillette Company Reduction of hair growth
EP1732500B1 (en) 2004-01-07 2018-11-21 E-L Management Corporation Cosmetic composition and method for retarding hair growth
ZA200609973B (en) * 2004-06-14 2008-06-25 Unilever Plc Method of decreasing sebum production and pore size
WO2009053493A1 (en) * 2007-10-26 2009-04-30 Galderma Research & Development Non-invasive method to perform skin inflammatory disease pharmaco-genomic studies and diagnosis method thereof
KR101035086B1 (ko) 2009-07-13 2011-05-19 (주)넥스젠바이오텍 담배거세미나방 유래의 ＯＤＣ Ａｚ 단백질 코딩 유전자 및 이의 용도
KR101035085B1 (ko) 2009-07-13 2011-05-19 (주)넥스젠바이오텍 담배거세미나방 유래의 ｏｄｃ 단백질 코딩 유전자 및 이의 용도
AU2013221317B2 (en) 2012-02-16 2017-07-06 Pangu Biopharma Limited Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
ITRM20120576A1 (it) * 2012-11-19 2014-05-20 Cinzia Marchese Composizione efficace nel rallentamento della crescita pilifera
EP3523274A4 (en) * 2016-10-06 2020-05-13 Orbus Therapeutics, Inc. FORMULATIONS FOR THE ADMINISTRATION OF EFLORNITHIN

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925012A (en) * 1968-08-02 1975-12-09 Bayer Ag Process for dyeing fibre material containing nh-groups from organic solvents
US4201788A (en) 1976-10-20 1980-05-06 University Patents, Inc. Process for alleviating proliferative skin diseases
US4496588A (en) 1977-07-11 1985-01-29 Merrell Toraude Et Compagnie Method of treating psoriasis
US4413141A (en) 1977-07-11 1983-11-01 Merrell Toraude Et Compagnie 2-(Difluoromethyl)-2,5-diaminopentanoic acid
US4421768A (en) 1982-08-11 1983-12-20 Merrell Toraude Et Compagnie Fluorinated diamino-heptene and-heptyne derivatives
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
JP2652870B2 (ja) 1988-04-06 1997-09-10 鐘紡株式会社 泡状除毛組成物
US5217886A (en) 1988-08-31 1993-06-08 Merrell Dow Pharmaceuticals Inc. Method for the production of (-)-4-difluoromethyl-ornithine
US5256396A (en) 1990-01-24 1993-10-26 Colgate-Palmolive Company Topical composition
US5096911A (en) 1990-06-25 1992-03-17 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
JPH0495019A (ja) 1990-08-10 1992-03-27 Shiseido Co Ltd 崩壊性泡状除毛剤
WO1992003140A1 (en) * 1990-08-14 1992-03-05 Handelman Joseph H Enzymic alteration of hair growth
US5095007A (en) 1990-10-24 1992-03-10 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
JP2986274B2 (ja) 1991-12-24 1999-12-06 鐘紡株式会社 クリーム状除毛剤組成物
AU3931093A (en) * 1993-03-19 1994-10-11 Handelman, Joseph H. Topical composition for inhibiting hair growth
US5648394A (en) * 1993-05-27 1997-07-15 Boxall; Brian Alfred Topical composition for inhibiting hair growth
US5945409A (en) * 1995-03-10 1999-08-31 Wilson T. Crandall Topical moisturizing composition and method
US5851537A (en) 1996-02-02 1998-12-22 Cancer Technologies, Inc. Topical application of α-DFMO for preventing skin cancer
WO1998025603A1 (en) 1996-12-13 1998-06-18 Ilex Oncology, Inc. Isomeric pharmaceutical formulation containing dfmo for the treatment of cancer
JPH11267105A (ja) 1998-03-23 1999-10-05 Shiseido Co Ltd 皮膚の測定方法及びこの方法に用いる蛍光色素浸潤用組成物
US20030036561A1 (en) * 2001-08-10 2003-02-20 Peter Styczynski Reduction of hair growth
US7261878B2 (en) 2001-08-10 2007-08-28 The Gillette Company Reduction of hair growth

Also Published As

Publication number Publication date
IL160131A (en) 2011-05-31
JP3981074B2 (ja) 2007-09-26
NZ531006A (en) 2005-01-28
KR100722001B1 (ko) 2007-05-25
RU2004107843A (ru) 2005-04-10
EP1416907A1 (en) 2004-05-12
CA2455231C (en) 2007-06-26
WO2003015729A1 (en) 2003-02-27
CA2455231A1 (en) 2003-02-27
JP2005505528A (ja) 2005-02-24
EP1416907A4 (en) 2005-07-20
CN1320878C (zh) 2007-06-13
US20030053973A1 (en) 2003-03-20
MXPA04001137A (es) 2005-02-17
KR20040054672A (ko) 2004-06-25
AR035133A1 (es) 2004-04-14
CN1555252A (zh) 2004-12-15
AU2002324699B2 (en) 2007-07-26
HK1073060A1 (en) 2005-09-23
US7374770B2 (en) 2008-05-20

Similar Documents

Publication Publication Date Title
AU2002340120A1 (en) Semisolid topical hormonal compositions and methods for treatment
HUP0300855A3 (en) Peptidmomimetic protease inhibitors, pharmaceutical compositions and their use
EP1368053A4 (en) COMPOSITIONS AND METHODS FOR TREATING GONADOTROPINE-RELATED DISEASES
HK1071886A1 (en) Novel compounds and compositions as cathepsin inhibitors
AU2001264729A1 (en) Thromboxane inhibitors, compositions and methods of use related applications
AU2001236457A1 (en) Compounds and compositions for delivering active agents
PT1461039E (pt) Composições farmacêuticas compreendendo cilostazol e um inibidor da captação de adenosina
EP1315500A4 (en) PHARMACEUTICAL COMPOSITIONS FOR TOPICAL ADMINISTRATION OF CYCLOOXYGENASE-2 INHIBITORS
AU2001249969A1 (en) Inha inhibitors and their use as antibacterials
AU2001296908A1 (en) Proton pump inhibitor formulation
AU2002220241A1 (en) Parb inhibitors
AU2001284985A1 (en) Compounds and compositions for delivering active agents
AU2003220361A1 (en) Benzamides and compositions benzamides for use as fungizide
IL160131A0 (en) Topical composition for follicular delivery of an ornithine decarboxylase inhibitor
IL205407A0 (en) Hyaluronic acid antagonist and inhibitor compositions and uses thereof
HUP0303272A3 (en) Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators, pharmaceutical compositions containing them and their use
IL161992A0 (en) Substituted 2-amino-cycloalkanecarboxamides and t heir use as cysteine protease inhibitors
AU2001288277A1 (en) Compounds and compositions for delivering active agents
AU2001245764A1 (en) Novel compounds and compositions as protease inhibitors
IL159125A0 (en) Novel compounds and compositions as cathepsin inhibitors
AU2001288395A1 (en) Method for enhanced delivery of oxybutynin and compositions thereof
EP1350522A4 (en) TOPICAL ANESTHESIA COMPOSITIONS
AU2002316200A1 (en) Compound and composition for delivering active agents
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
GB2407862B (en) Freeze-thaw valve that self-limits cryogenic agent usage